
<!-- saved from url=(0081)https://www.sec.gov/Archives/edgar/data/1382911/000119312519155290/d753779d8k.htm -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252"></head><body bgcolor="WHITE"><document>
<type>8-K
<sequence>1
<filename>d753779d8k.htm
<description>8-K
<text>

<title>8-K</title>

 


<center><div style="width:8.5in" align="left">
 <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</p>
<p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" align="center"><b>UNITED STATES </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" align="center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" align="center"><b>WASHINGTON, D.C. 20549</b></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center>
<p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" align="center"><b>FORM <font style="white-space:nowrap">8-K</font></b></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center>
<p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" align="center"><b>CURRENT
REPORT </b></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" align="center"><b>Pursuant to Section&nbsp;13 or 15(d) </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" align="center"><b>of The Securities Exchange Act of 1934 </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" align="center"><b>Date of Report (Date of earliest event reported): May&nbsp;17, 2019</b></p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" align="center"><b>Orexigen Therapeutics, Inc. </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>(Exact name of registrant as specified in charter)</b></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center>
<p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" align="center">


<tbody><tr>
<td width="34%"></td>
<td valign="bottom"></td>
<td width="32%"></td>
<td valign="bottom" width="1%"></td>
<td width="32%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" align="center"><b>Delaware</b></td>
<td valign="bottom">&nbsp;</td>
<td valign="top" align="center"><b><font style="white-space:nowrap">001-33415</font></b></td>
<td valign="bottom">&nbsp;</td>
<td valign="top" align="center"><b><font style="white-space:nowrap">65-1178822</font></b></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td valign="top" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" align="center"><b>(State or other jurisdiction</b></p>
<p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" align="center"><b>of incorporation)</b></p></td>
<td valign="bottom">&nbsp;</td>
<td valign="top" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" align="center"><b>(Commission</b></p>
<p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" align="center"><b>File Number)</b></p></td>
<td valign="bottom">&nbsp;</td>
<td valign="top" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" align="center"><b>(IRS Employer</b></p>
<p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" align="center"><b>Identification No.)</b></p></td></tr>
</tbody></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="90%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>
<td width="51%"></td>
<td valign="bottom" width="2%"></td>
<td width="47%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" align="center"><b>3344 N. Torrey Pines Ct., Suite 200, La Jolla, CA</b></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top" align="center"><b>92037</b></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td valign="top" align="center"><b>(Address of principal executive offices)</b></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top" align="center"><b>(Zip Code)</b></td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>Registrant’s telephone number, including area code: (858)
<font style="white-space:nowrap">875-8600</font> </b></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" align="center"><b>(Former name or former address, if changed since last report.)</b></p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <font style="white-space:nowrap">8-K</font> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below): </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%" valign="top" align="left">&#9744;</td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td></tr></tbody></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%" valign="top" align="left">&#9744;</td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left">Soliciting material pursuant to Rule <font style="white-space:nowrap">14a-12</font> under the Exchange Act (17
CFR <font style="white-space:nowrap">240.14a-12)</font> </p></td></tr></tbody></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%" valign="top" align="left">&#9744;</td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left"><font style="white-space:nowrap">Pre-commencement</font> communication pursuant to Rule <font style="white-space:nowrap">14d-2(b)</font> under the Exchange Act (17 CFR <font style="white-space:nowrap">240.14d-2(b))</font> </p></td></tr></tbody></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%" valign="top" align="left">&#9744;</td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left"><font style="white-space:nowrap">Pre-commencement</font> communication pursuant to Rule <font style="white-space:nowrap">13e-4(c)</font> under the Exchange Act (17 CFR <font style="white-space:nowrap">240.13e-4(c))</font> </p></td></tr></tbody></table>
<p style="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&nbsp;12(b) of the Act: </p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>
<td width="34%"></td>
<td valign="bottom"></td>
<td width="32%"></td>
<td valign="bottom" width="1%"></td>
<td width="32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td valign="bottom" nowrap="" align="center" style="border-bottom:1.00pt solid #000000"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" align="center"><b>Title of each class</b></p></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="center" style="border-bottom:1.00pt solid #000000"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" align="center"><b>Trading</b></p>
<p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" align="center"><b>Symbol(s)</b></p></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="center" style="border-bottom:1.00pt solid #000000"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" align="center"><b>Name of each exchange on which registered</b></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" align="center"><b>None</b></td>
<td valign="bottom">&nbsp;</td>
<td valign="top" align="center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="center"><b>N/A</b></p></td>
<td valign="bottom">&nbsp;</td>
<td valign="top" align="center"><b>N/A</b></td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule <font style="white-space:nowrap">12b-2</font> of the Securities Exchange Act of 1934 <font style="white-space:nowrap">(§240.12b-2</font> of this chapter). </p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="right">Emerging growth company&nbsp;&nbsp;&#9744; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange
Act.&nbsp;&nbsp;&#9744; </p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</p>
<p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</p>
</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="9%" valign="top" align="left"><b>Item&nbsp;1.03.</b></td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left"><b>Bankruptcy or Receivership. </b></p></td></tr></tbody></table>
<p style="margin-top:6pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on March&nbsp;12, 2018, Orexigen Therapeutics, Inc. (the “Company”) filed a voluntary petition for
bankruptcy protection under Chapter 11 of Title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) (Case
<font style="white-space:nowrap">No.&nbsp;18-10518).</font> On May&nbsp;17, 2019, the Bankruptcy Court entered an order (the “Confirmation Order”) confirming the Debtor’s Modified Amended Plan of Liquidation (the “Plan of
Liquidation”) filed by the Company. A copy of the Plan of Liquidation is filed as Exhibit 2.1 to this Current Report on Form <font style="white-space:nowrap">8-K</font> and incorporated by reference into this Item 1.03. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><b><i>Summary of Plan </i></b></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">The Plan of
Liquidation, as confirmed by the Bankruptcy Court, creates seven classes of claims against and interests in the Company. Holders of allowed claims in Class&nbsp;1 (Priority Claims), Class&nbsp;2 (Other Secured Claims), Class&nbsp;3 (Prepetition
Secured Noteholder Claims), and Class&nbsp;4 (General Unsecured Claims), are entitled to receive distributions under the Plan of Liquidation. If all General Unsecured Claims are paid in full (which is not anticipated), holders of allowed claims in
Class&nbsp;5 (Prepetition Secured Noteholder Subordinated Deficiency Claim) would be entitled to receive a distribution under the Plan of Liquidation. In addition, the Company will be paying Administrative Expense Claims, Professional Fee Claims and
Priority Tax Claims under the Plan of Liquidation. Pursuant to the Plan of Liquidation, upon the effectiveness thereof, a wind down entity will be formed in the form of a liquidating trust to liquidate the Company’s remaining assets and pursue
certain causes of action held by the Company and other recoveries for the benefit of unsecured creditors and the Company’s prepetition secured noteholders, as applicable. The Plan of Liquidation also implements the terms of certain settlements
among various creditor constituencies, without which the Company believes recoveries to creditors would be materially reduced. Certain reserves will be created by the wind down entity for purposes of resolving disputed claims and ongoing disputes,
and funding various costs and expenses associated with the administration of the wind down entity and Plan of Liquidation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">The Plan of
Liquidation further provides that all outstanding equity interests in the Company will be cancelled for no consideration on the effective date of the Plan of Liquidation. As of May&nbsp;17, 2019, the Company had 18,887,033 shares of common stock
issued and outstanding, 219,994 shares of Series Z Preferred Stock issued and outstanding, and no shares reserved for future issuance in respect of claims and interests filed and allowed under the Plan of Liquidation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">The Plan of Liquidation will become effective on the first business day on which the following conditions have been satisfied or waived:
(i)&nbsp;the Confirmation has been entered by the Bankruptcy Court and has become final; and (ii)&nbsp;the wind down entity has been created. The Company anticipates the effective date of the Plan of Liquidation will occur on or around May&nbsp;31,
2019. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><b><i>Assets and Liabilities </i></b></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2019, the Company had total assets of $33,072 and total liabilities of $252,569, as disclosed in the Company’s most
recent monthly operating report filed with the Bankruptcy Court on April&nbsp;29, 2019 and furnished as Exhibit 99.1 to the Company’s Current Report on Form <font style="white-space:nowrap">8-K</font> furnished on May&nbsp;3, 2019. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><b><i>Cautionary Statements Regarding Trading in the Company’s Securities </i></b></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">The Company’s securityholders are cautioned that trading in the Company’s securities during the pendency of the Chapter 11 process
will be highly speculative and will pose substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by holders thereof in the Company’s Chapter 11 process. Accordingly,
the Company urges extreme caution with respect to existing and future investments in its securities. As noted above, the Plan of Liquidation will cause all outstanding equity interests in the Company to be cancelled on the effective date of the Plan
of Liquidation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><b><i>Cautionary Statement Regarding Forward-Looking Statements </i></b></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">This Current Report on <font style="white-space:nowrap">Form&nbsp;8-K&nbsp;and</font> Exhibit 99.1 hereto may contain “forward-looking
statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those involving future events and future results that are based on current expectations, estimates, forecasts, and
projections as well as the current beliefs and assumptions of the Company’s management. We often use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,”
“believe,” “may,” “predict,” “will,” “would,” “could,” “should,” “target” and similar expressions to identify forward-looking statements. All statements contained in
this Current Report and exhibits hereto that are not statements of historical fact and other estimates, projections, future trends and the outcome of events that have not yet occurred referenced in this Current Report and exhibits hereto should be
considered forward-looking statements. Actual results or events could differ materially from those indicated in forward-looking statements as a result of risks and uncertainties, including, among others, the potential adverse impact of the Chapter
11 filings on our liquidity or results of operations, changes in our ability to meet financial obligations during the Chapter 11 process or to maintain contracts that are critical to our operations, the outcome or timing of the Chapter 11 process,
the effect of the Chapter 11 filings or related asset sale on our relationships with third parties, regulatory authorities and employees, proceedings that may be brought by third parties in connection with the Chapter 11 process and the timing or
amount of any distributions to the Company’s stakeholders. Many of such factors relate to events and circumstances that are beyond the Company’s control. You should not place undue reliance on forward-looking statements. The Company does
not assume any obligation to update the information contained in this Current Report or exhibits hereto. </p>
</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><b><i>Additional Information regarding the Chapter 11 Case </i></b></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">Additional information about the Chapter 11 process and Plan of Liquidation, as well as other documents related to the case, is available
through the Company’s claims agent Kurtzman Carson Consultants LLC at<i>&nbsp;www.kccllc.net/orexigen</i>. Information contained on, or that can be accessed through, such web site or the Bankruptcy Court’s web site is not part of this
Current Report. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="9%" valign="top" align="left"><b>Item&nbsp;9.01.</b></td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left"><b>Financial Statements and Exhibits. </b></p></td></tr></tbody></table>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%" valign="top" align="left">(d)</td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left">&nbsp;&nbsp;&nbsp;&nbsp;Exhibits. </p></td></tr></tbody></table>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%" valign="top" align="left">2.1</td>
<td align="left" valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " align="left">&nbsp;&nbsp;&nbsp;&nbsp;<a href="https://www.sec.gov/Archives/edgar/data/1382911/000119312519155290/d753779dex21.htm">Debtor’s Modified Amended Plan of Liquidation. </a>
</p></td></tr></tbody></table>
</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" align="center"><b>SIGNATURES </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<tbody><tr>
<td width="44%"></td>
<td valign="bottom" width="1%"></td>
<td width="4%"></td>
<td valign="bottom"></td>
<td width="5%"></td>
<td valign="bottom" width="1%"></td>
<td width="44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="top" colspan="3">OREXIGEN THERAPEUTICS, INC.</td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td valign="top">Date: May 23, 2019</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="top">By:</td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000">&nbsp;</td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000">/s/ Thomas P. Lynch</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="top">Name:</td>
<td valign="bottom">&nbsp;</td>
<td valign="top">Thomas P. Lynch</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="top">Title:</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom">Chief Administrative Officer, General Counsel, President, Secretary and Treasurer</td></tr>
</tbody></table>
</div></center>


</text>
</description></filename></sequence></type></document>
</body></html>